

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.80461974 |
| 2 | axon ensheathment (GO:0008366) | 7.54231828 |
| 3 | ensheathment of neurons (GO:0007272) | 7.54231828 |
| 4 | myelination (GO:0042552) | 7.50679705 |
| 5 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.06800786 |
| 6 | myelin maintenance (GO:0043217) | 5.77039745 |
| 7 | apical protein localization (GO:0045176) | 5.58294202 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.57845442 |
| 9 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.44740871 |
| 10 | glycerophospholipid catabolic process (GO:0046475) | 5.40529377 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.27607456 |
| 12 | oligodendrocyte differentiation (GO:0048709) | 5.20871182 |
| 13 | asymmetric protein localization (GO:0008105) | 5.13484413 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.84925296 |
| 15 | negative regulation of neurotransmitter transport (GO:0051589) | 4.75944530 |
| 16 | cholesterol biosynthetic process (GO:0006695) | 4.73548898 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.72046273 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.65544709 |
| 19 | establishment of mitochondrion localization (GO:0051654) | 4.59050415 |
| 20 | eye photoreceptor cell differentiation (GO:0001754) | 4.58836345 |
| 21 | photoreceptor cell differentiation (GO:0046530) | 4.58836345 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.58489037 |
| 23 | negative regulation of cell killing (GO:0031342) | 4.58489037 |
| 24 | creatine metabolic process (GO:0006600) | 4.56832161 |
| 25 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.56756476 |
| 26 | negative regulation of protein localization to cell surface (GO:2000009) | 4.55664562 |
| 27 | regulation of collateral sprouting (GO:0048670) | 4.43933972 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.30172398 |
| 29 | virion attachment to host cell (GO:0019062) | 4.24035216 |
| 30 | adhesion of symbiont to host cell (GO:0044650) | 4.24035216 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 4.21169003 |
| 32 | astrocyte development (GO:0014002) | 4.20741802 |
| 33 | sterol biosynthetic process (GO:0016126) | 4.12384943 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.11983904 |
| 35 | presynaptic membrane organization (GO:0097090) | 4.11075397 |
| 36 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.01977628 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.00846414 |
| 38 | response to redox state (GO:0051775) | 3.98658157 |
| 39 | neutrophil activation (GO:0042119) | 3.97868710 |
| 40 | granulocyte activation (GO:0036230) | 3.93595410 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 3.90485613 |
| 42 | substantia nigra development (GO:0021762) | 3.89293086 |
| 43 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.88341596 |
| 44 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.88341596 |
| 45 | modulation by symbiont of host immune response (GO:0052553) | 3.88341596 |
| 46 | positive regulation by symbiont of host defense response (GO:0052509) | 3.88341596 |
| 47 | modulation by symbiont of host defense response (GO:0052031) | 3.88341596 |
| 48 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.88341596 |
| 49 | presynaptic membrane assembly (GO:0097105) | 3.88229927 |
| 50 | negative regulation of JUN kinase activity (GO:0043508) | 3.85799707 |
| 51 | membrane tubulation (GO:0097320) | 3.85023988 |
| 52 | detection of other organism (GO:0098543) | 3.83180684 |
| 53 | regulation of regulatory T cell differentiation (GO:0045589) | 3.82108781 |
| 54 | response to peptidoglycan (GO:0032494) | 3.79673262 |
| 55 | leukocyte aggregation (GO:0070486) | 3.76683821 |
| 56 | B cell mediated immunity (GO:0019724) | 3.71307568 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 3.70845335 |
| 58 | response to interleukin-15 (GO:0070672) | 3.69550591 |
| 59 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.68221425 |
| 60 | detection of bacterium (GO:0016045) | 3.67916781 |
| 61 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.67355811 |
| 62 | cytidine metabolic process (GO:0046087) | 3.66073300 |
| 63 | cytidine catabolic process (GO:0006216) | 3.66073300 |
| 64 | cytidine deamination (GO:0009972) | 3.66073300 |
| 65 | response to lipoprotein particle (GO:0055094) | 3.64432729 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.63662176 |
| 67 | isoprenoid biosynthetic process (GO:0008299) | 3.63246842 |
| 68 | macrophage activation involved in immune response (GO:0002281) | 3.61445841 |
| 69 | GPI anchor biosynthetic process (GO:0006506) | 3.60344080 |
| 70 | positive regulation of mast cell activation (GO:0033005) | 3.59406572 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 3.58298959 |
| 72 | amyloid precursor protein metabolic process (GO:0042982) | 3.55473646 |
| 73 | cellular response to interleukin-15 (GO:0071350) | 3.53989752 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 3.53129660 |
| 75 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.52681221 |
| 76 | import into cell (GO:0098657) | 3.49285310 |
| 77 | GPI anchor metabolic process (GO:0006505) | 3.47027224 |
| 78 | regulation of B cell differentiation (GO:0045577) | 3.45433186 |
| 79 | B cell receptor signaling pathway (GO:0050853) | 3.44716622 |
| 80 | positive regulation of action potential (GO:0045760) | 3.43984419 |
| 81 | protein palmitoylation (GO:0018345) | 3.42041818 |
| 82 | cellular extravasation (GO:0045123) | 3.39095008 |
| 83 | tolerance induction (GO:0002507) | 3.38042187 |
| 84 | limb bud formation (GO:0060174) | 3.37535089 |
| 85 | positive thymic T cell selection (GO:0045059) | 3.35337258 |
| 86 | leukocyte degranulation (GO:0043299) | 3.34475558 |
| 87 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.33899344 |
| 88 | regulation of T cell tolerance induction (GO:0002664) | 3.33818965 |
| 89 | respiratory burst (GO:0045730) | 3.30434939 |
| 90 | myelination in peripheral nervous system (GO:0022011) | 3.29511321 |
| 91 | peripheral nervous system axon ensheathment (GO:0032292) | 3.29511321 |
| 92 | positive regulation of mast cell degranulation (GO:0043306) | 3.28247307 |
| 93 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.28247307 |
| 94 | microtubule polymerization or depolymerization (GO:0031109) | 3.27133717 |
| 95 | adult walking behavior (GO:0007628) | 3.26975180 |
| 96 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.25086257 |
| 97 | response to methylmercury (GO:0051597) | 3.23699651 |
| 98 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.23546100 |
| 99 | detection of external biotic stimulus (GO:0098581) | 3.23191474 |
| 100 | ear development (GO:0043583) | 3.22434657 |
| 101 | negative T cell selection (GO:0043383) | 3.21710966 |
| 102 | positive regulation of glial cell differentiation (GO:0045687) | 3.21300643 |
| 103 | regulation of tolerance induction (GO:0002643) | 3.21011426 |
| 104 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.19658229 |
| 105 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.19433054 |
| 106 | axon development (GO:0061564) | 3.17007853 |
| 107 | negative thymic T cell selection (GO:0045060) | 3.16917138 |
| 108 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.16559387 |
| 109 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.16307943 |
| 110 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.16270870 |
| 111 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.15940029 |
| 112 | adhesion of symbiont to host (GO:0044406) | 3.13499191 |
| 113 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.13347830 |
| 114 | glycosylceramide metabolic process (GO:0006677) | 3.13319660 |
| 115 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.11005290 |
| 116 | L-amino acid import (GO:0043092) | 3.09733729 |
| 117 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.08506552 |
| 118 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.07079807 |
| 119 | nucleotide transmembrane transport (GO:1901679) | 3.06206632 |
| 120 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06153563 |
| 121 | regulation of mast cell activation (GO:0033003) | 3.06018900 |
| 122 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.04626128 |
| 123 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.04336710 |
| 124 | negative regulation of axonogenesis (GO:0050771) | 3.02824689 |
| 125 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.02313232 |
| 126 | mast cell activation (GO:0045576) | 3.02071994 |
| 127 | positive regulation of tolerance induction (GO:0002645) | 3.01127537 |
| 128 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.00917505 |
| 129 | transmission of nerve impulse (GO:0019226) | 3.00274854 |
| 130 | detection of molecule of bacterial origin (GO:0032490) | 2.99984240 |
| 131 | negative regulation of T cell mediated immunity (GO:0002710) | 2.99876245 |
| 132 | peptidyl-cysteine modification (GO:0018198) | 2.98906788 |
| 133 | nerve growth factor signaling pathway (GO:0038180) | 2.98780182 |
| 134 | glial cell development (GO:0021782) | 2.98656471 |
| 135 | response to host immune response (GO:0052572) | 2.98182495 |
| 136 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.98182495 |
| 137 | defense response to protozoan (GO:0042832) | 2.98105664 |
| 138 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.97209880 |
| 139 | organ growth (GO:0035265) | 2.97155067 |
| 140 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96179206 |
| 141 | negative regulation of acute inflammatory response (GO:0002674) | 2.95932718 |
| 142 | T cell migration (GO:0072678) | 2.95480223 |
| 143 | magnesium ion transport (GO:0015693) | 2.95186583 |
| 144 | regulation of leukocyte degranulation (GO:0043300) | 2.94225494 |
| 145 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.93442951 |
| 146 | microglial cell activation (GO:0001774) | 2.93142314 |
| 147 | regulation of lipoprotein metabolic process (GO:0050746) | 2.92733823 |
| 148 | Leydig cell differentiation (GO:0033327) | 2.90707808 |
| 149 | type I interferon signaling pathway (GO:0060337) | 2.89828632 |
| 150 | cellular response to type I interferon (GO:0071357) | 2.89828632 |
| 151 | amyloid precursor protein catabolic process (GO:0042987) | 2.89772437 |
| 152 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.88821349 |
| 153 | positive regulation of gliogenesis (GO:0014015) | 2.88432390 |
| 154 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.88082393 |
| 155 | negative regulation of T cell apoptotic process (GO:0070233) | 2.87788700 |
| 156 | regulation of somitogenesis (GO:0014807) | 2.87407691 |
| 157 | neutrophil mediated immunity (GO:0002446) | 2.87255325 |
| 158 | response to type I interferon (GO:0034340) | 2.86629218 |
| 159 | positive T cell selection (GO:0043368) | 2.86492465 |
| 160 | T cell selection (GO:0045058) | 2.86001979 |
| 161 | mature B cell differentiation involved in immune response (GO:0002313) | 2.84886221 |
| 162 | detection of biotic stimulus (GO:0009595) | 2.84195917 |
| 163 | peripheral nervous system development (GO:0007422) | 2.82864135 |
| 164 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82180656 |
| 165 | chaperone-mediated protein transport (GO:0072321) | 2.81949973 |
| 166 | negative regulation of macroautophagy (GO:0016242) | 2.81287214 |
| 167 | macrophage activation (GO:0042116) | 2.80918036 |
| 168 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.80804086 |
| 169 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.80804086 |
| 170 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.80151670 |
| 171 | membrane raft organization (GO:0031579) | 2.79166772 |
| 172 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.78953175 |
| 173 | positive regulation of granulocyte differentiation (GO:0030854) | 2.78834677 |
| 174 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.78756663 |
| 175 | DNA deamination (GO:0045006) | 2.77885392 |
| 176 | regulation of antigen processing and presentation (GO:0002577) | 2.77847329 |
| 177 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.77825168 |
| 178 | protein neddylation (GO:0045116) | 2.77165072 |
| 179 | cellular response to epinephrine stimulus (GO:0071872) | 2.76594793 |
| 180 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.74192502 |
| 181 | histone H2B ubiquitination (GO:0033523) | 2.73955267 |
| 182 | response to interferon-beta (GO:0035456) | 2.73279463 |
| 183 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.72677842 |
| 184 | very long-chain fatty acid metabolic process (GO:0000038) | 2.67734900 |
| 185 | dopamine biosynthetic process (GO:0042416) | 2.66060720 |
| 186 | positive regulation of actin filament depolymerization (GO:0030836) | 2.65515232 |
| 187 | protein polyglutamylation (GO:0018095) | 2.65262751 |
| 188 | mannosylation (GO:0097502) | 2.63707094 |
| 189 | glial cell differentiation (GO:0010001) | 2.61584553 |
| 190 | regulation of dopamine metabolic process (GO:0042053) | 2.61286436 |
| 191 | regulation of catecholamine metabolic process (GO:0042069) | 2.61286436 |
| 192 | positive regulation of cell fate commitment (GO:0010455) | 2.57501142 |
| 193 | negative regulation of inclusion body assembly (GO:0090084) | 2.57477705 |
| 194 | positive regulation of interleukin-17 production (GO:0032740) | 2.56415629 |
| 195 | neural nucleus development (GO:0048857) | 2.49898034 |
| 196 | response to lead ion (GO:0010288) | 2.49285797 |
| 197 | lateral sprouting from an epithelium (GO:0060601) | 2.48651791 |
| 198 | axon ensheathment in central nervous system (GO:0032291) | 12.2994295 |
| 199 | central nervous system myelination (GO:0022010) | 12.2994295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.81656715 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.33630911 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.87054695 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.85020669 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50833010 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.43741619 |
| 7 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.27136994 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.22200083 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.03559842 |
| 10 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.82696447 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.76868863 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74670787 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73162406 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.70889215 |
| 15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67357982 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.66937412 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.62287690 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.59250854 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.55280822 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.54455628 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48651004 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.47364982 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37939295 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.37409552 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.31729904 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.30708569 |
| 27 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.30596237 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.30565779 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.20752324 |
| 30 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.20605911 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 2.09161003 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.07812394 |
| 33 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.07676723 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.05374644 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 2.04071952 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02169183 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01254968 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01158880 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 2.00959728 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.98159532 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.92881913 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.92340700 |
| 43 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.90882668 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89666424 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88824442 |
| 46 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87924933 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.85999351 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85788682 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85119047 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84194751 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83676753 |
| 52 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82679731 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.81190017 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78181687 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77573141 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77006572 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.75330890 |
| 58 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.75132109 |
| 59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73155811 |
| 60 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.71344692 |
| 61 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.70610279 |
| 62 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.70216343 |
| 63 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.70216343 |
| 64 | MYC_22102868_ChIP-Seq_BL_Human | 1.68101266 |
| 65 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.65552338 |
| 66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.64150769 |
| 67 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63212587 |
| 68 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.63003038 |
| 69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56221073 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55054275 |
| 71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54967372 |
| 72 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54362608 |
| 73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54126125 |
| 74 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.52963184 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52962805 |
| 76 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.51002292 |
| 77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50703139 |
| 78 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48002472 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.46956775 |
| 80 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.46165753 |
| 81 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46057672 |
| 82 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.44457376 |
| 83 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44099450 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43934073 |
| 85 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43343714 |
| 86 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.41872981 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40156069 |
| 88 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.40093651 |
| 89 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39769587 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 1.39643138 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.38602195 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37657873 |
| 93 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37049716 |
| 94 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.36654462 |
| 95 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35949352 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31747207 |
| 97 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31497327 |
| 98 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31461047 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30875377 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30461922 |
| 101 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27800674 |
| 102 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27061852 |
| 103 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26361015 |
| 104 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25703752 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25512157 |
| 106 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25231379 |
| 107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25076904 |
| 108 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.24442144 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23618033 |
| 110 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.22881930 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22501339 |
| 112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22061989 |
| 113 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.21952009 |
| 114 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21409891 |
| 115 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.21282865 |
| 116 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20430974 |
| 117 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.20221061 |
| 118 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.19625509 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19447644 |
| 120 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19376728 |
| 121 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19158688 |
| 122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18997624 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18812053 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18812053 |
| 125 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.18462962 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17716880 |
| 127 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16702081 |
| 128 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16497473 |
| 129 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15973720 |
| 130 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15908507 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15835527 |
| 132 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.15611761 |
| 133 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14875584 |
| 134 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14802295 |
| 135 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14778356 |
| 136 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13544509 |
| 137 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13264454 |
| 138 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13227046 |
| 139 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13051631 |
| 140 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12752189 |
| 141 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.12349612 |
| 142 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11908670 |
| 143 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09538581 |
| 144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08595596 |
| 145 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.08588022 |
| 146 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08489906 |
| 147 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.07861894 |
| 148 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07641193 |
| 149 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07087949 |
| 150 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07003718 |
| 151 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06221324 |
| 152 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05411986 |
| 153 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04863857 |
| 154 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04676103 |
| 155 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 1.04468356 |
| 156 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.03272985 |
| 157 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01662675 |
| 158 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01369473 |
| 159 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00196899 |
| 160 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00039126 |
| 161 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99814334 |
| 162 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99394399 |
| 163 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99394399 |
| 164 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98719387 |
| 165 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98496221 |
| 166 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98142410 |
| 167 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97466911 |
| 168 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.97380147 |
| 169 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96637387 |
| 170 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96133019 |
| 171 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95143936 |
| 172 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94988712 |
| 173 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.94796439 |
| 174 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94584776 |
| 175 | EWS_26573619_Chip-Seq_HEK293_Human | 0.94509969 |
| 176 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93961774 |
| 177 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93606565 |
| 178 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.93461871 |
| 179 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93443144 |
| 180 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93442006 |
| 181 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92111394 |
| 182 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91796082 |
| 183 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.91598981 |
| 184 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91304881 |
| 185 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90770643 |
| 186 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.90460632 |
| 187 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90313279 |
| 188 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.89952191 |
| 189 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89772289 |
| 190 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89233638 |
| 191 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86227282 |
| 192 | P300_27268052_Chip-Seq_Bcells_Human | 0.84161269 |
| 193 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83621568 |
| 194 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.82673001 |
| 195 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82157487 |
| 196 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79848643 |
| 197 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.79669280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.95510772 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.51511627 |
| 3 | MP0003724_increased_susceptibility_to | 3.92520735 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.90427429 |
| 5 | MP0003880_abnormal_central_pattern | 3.71262626 |
| 6 | MP0004270_analgesia | 3.59612419 |
| 7 | MP0003436_decreased_susceptibility_to | 3.52570247 |
| 8 | MP0005671_abnormal_response_to | 3.47217827 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.05226472 |
| 10 | MP0003690_abnormal_glial_cell | 3.00628664 |
| 11 | MP0003303_peritoneal_inflammation | 2.98240206 |
| 12 | MP0001529_abnormal_vocalization | 2.93106076 |
| 13 | MP0009785_altered_susceptibility_to | 2.87713877 |
| 14 | MP0002419_abnormal_innate_immunity | 2.86798575 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.85812055 |
| 16 | MP0005025_abnormal_response_to | 2.85540348 |
| 17 | MP0001905_abnormal_dopamine_level | 2.83841980 |
| 18 | MP0003136_yellow_coat_color | 2.83267862 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.82459306 |
| 20 | MP0003329_amyloid_beta_deposits | 2.82227987 |
| 21 | MP0001800_abnormal_humoral_immune | 2.80146877 |
| 22 | MP0005387_immune_system_phenotype | 2.73596696 |
| 23 | MP0001790_abnormal_immune_system | 2.73596696 |
| 24 | MP0004885_abnormal_endolymph | 2.65731262 |
| 25 | MP0002723_abnormal_immune_serum | 2.61860852 |
| 26 | MP0004742_abnormal_vestibular_system | 2.54513154 |
| 27 | MP0005171_absent_coat_pigmentation | 2.52783156 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.49964427 |
| 29 | MP0005451_abnormal_body_composition | 2.46581074 |
| 30 | MP0002452_abnormal_antigen_presenting | 2.46557993 |
| 31 | MP0001819_abnormal_immune_cell | 2.46190766 |
| 32 | MP0003763_abnormal_thymus_physiology | 2.44268983 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 2.43828667 |
| 34 | MP0000685_abnormal_immune_system | 2.41303256 |
| 35 | MP0001485_abnormal_pinna_reflex | 2.40150324 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 2.39797274 |
| 37 | MP0003634_abnormal_glial_cell | 2.26212262 |
| 38 | MP0002272_abnormal_nervous_system | 2.24631182 |
| 39 | MP0002132_abnormal_respiratory_system | 2.07586923 |
| 40 | MP0002398_abnormal_bone_marrow | 2.02183705 |
| 41 | MP0002405_respiratory_system_inflammati | 2.01881857 |
| 42 | MP0001486_abnormal_startle_reflex | 2.01344902 |
| 43 | MP0000462_abnormal_digestive_system | 1.98774286 |
| 44 | MP0010678_abnormal_skin_adnexa | 1.97618307 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.96247200 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.94028256 |
| 47 | MP0005410_abnormal_fertilization | 1.93851309 |
| 48 | MP0000778_abnormal_nervous_system | 1.92751867 |
| 49 | MP0000716_abnormal_immune_system | 1.91892456 |
| 50 | MP0004142_abnormal_muscle_tone | 1.88198727 |
| 51 | MP0002229_neurodegeneration | 1.84834575 |
| 52 | MP0003632_abnormal_nervous_system | 1.83599347 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.82167447 |
| 54 | MP0000383_abnormal_hair_follicle | 1.81949866 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.80771226 |
| 56 | MP0005409_darkened_coat_color | 1.79641125 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.79098944 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.77712106 |
| 59 | MP0004381_abnormal_hair_follicle | 1.76547161 |
| 60 | MP0003075_altered_response_to | 1.69710078 |
| 61 | MP0002064_seizures | 1.69436849 |
| 62 | MP0004859_abnormal_synaptic_plasticity | 1.68058661 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.67271007 |
| 64 | MP0002722_abnormal_immune_system | 1.67071954 |
| 65 | MP0004947_skin_inflammation | 1.64882896 |
| 66 | MP0001346_abnormal_lacrimal_gland | 1.64644204 |
| 67 | MP0009764_decreased_sensitivity_to | 1.60527163 |
| 68 | MP0002429_abnormal_blood_cell | 1.59914612 |
| 69 | MP0002734_abnormal_mechanical_nocicepti | 1.53812816 |
| 70 | MP0008260_abnormal_autophagy | 1.53234437 |
| 71 | MP0008469_abnormal_protein_level | 1.51365432 |
| 72 | MP0009278_abnormal_bone_marrow | 1.51310496 |
| 73 | MP0001873_stomach_inflammation | 1.50763389 |
| 74 | MP0004147_increased_porphyrin_level | 1.49969792 |
| 75 | MP0003866_abnormal_defecation | 1.48904232 |
| 76 | MP0004043_abnormal_pH_regulation | 1.48902216 |
| 77 | MP0001853_heart_inflammation | 1.48583907 |
| 78 | MP0001545_abnormal_hematopoietic_system | 1.47060085 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 1.47060085 |
| 80 | MP0008004_abnormal_stomach_pH | 1.46555062 |
| 81 | MP0000579_abnormal_nail_morphology | 1.44288596 |
| 82 | MP0000703_abnormal_thymus_morphology | 1.44109498 |
| 83 | MP0000604_amyloidosis | 1.43233751 |
| 84 | MP0009046_muscle_twitch | 1.40845578 |
| 85 | MP0001851_eye_inflammation | 1.40138931 |
| 86 | MP0000955_abnormal_spinal_cord | 1.38926142 |
| 87 | MP0004134_abnormal_chest_morphology | 1.38659380 |
| 88 | MP0003718_maternal_effect | 1.36657790 |
| 89 | MP0003172_abnormal_lysosome_physiology | 1.31633969 |
| 90 | MP0002396_abnormal_hematopoietic_system | 1.31328840 |
| 91 | MP0002166_altered_tumor_susceptibility | 1.30726266 |
| 92 | MP0001963_abnormal_hearing_physiology | 1.30398749 |
| 93 | MP0000343_altered_response_to | 1.28439903 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 1.27911243 |
| 95 | MP0000566_synostosis | 1.27149289 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 1.26254339 |
| 97 | MP0005408_hypopigmentation | 1.26071634 |
| 98 | MP0004145_abnormal_muscle_electrophysio | 1.25801820 |
| 99 | MP0001299_abnormal_eye_distance/ | 1.24161806 |
| 100 | MP0003635_abnormal_synaptic_transmissio | 1.23774077 |
| 101 | MP0003828_pulmonary_edema | 1.23113096 |
| 102 | MP0002882_abnormal_neuron_morphology | 1.22412831 |
| 103 | MP0001661_extended_life_span | 1.20396735 |
| 104 | MP0009745_abnormal_behavioral_response | 1.20282583 |
| 105 | MP0005310_abnormal_salivary_gland | 1.20173710 |
| 106 | MP0002277_abnormal_respiratory_mucosa | 1.19473942 |
| 107 | MP0005551_abnormal_eye_electrophysiolog | 1.18897067 |
| 108 | MP0000858_altered_metastatic_potential | 1.18400723 |
| 109 | MP0002998_abnormal_bone_remodeling | 1.17220244 |
| 110 | MP0003631_nervous_system_phenotype | 1.16813555 |
| 111 | MP0004510_myositis | 1.15274563 |
| 112 | MP0003938_abnormal_ear_development | 1.14745456 |
| 113 | MP0005386_behavior/neurological_phenoty | 1.14459016 |
| 114 | MP0004924_abnormal_behavior | 1.14459016 |
| 115 | MP0002752_abnormal_somatic_nervous | 1.13439324 |
| 116 | MP0005423_abnormal_somatic_nervous | 1.11446662 |
| 117 | MP0001440_abnormal_grooming_behavior | 1.10169951 |
| 118 | MP0005166_decreased_susceptibility_to | 1.10087021 |
| 119 | MP0002066_abnormal_motor_capabilities/c | 1.09259434 |
| 120 | MP0000747_muscle_weakness | 1.08526747 |
| 121 | MP0000762_abnormal_tongue_morphology | 1.07931100 |
| 122 | MP0009763_increased_sensitivity_to | 1.03984349 |
| 123 | MP0002295_abnormal_pulmonary_circulatio | 0.99918558 |
| 124 | MP0003448_altered_tumor_morphology | 0.97719382 |
| 125 | MP0003183_abnormal_peptide_metabolism | 0.95524839 |
| 126 | MP0002572_abnormal_emotion/affect_behav | 0.95108770 |
| 127 | MP0001970_abnormal_pain_threshold | 0.94314072 |
| 128 | MP0005195_abnormal_posterior_eye | 0.91581541 |
| 129 | MP0001348_abnormal_lacrimal_gland | 0.89746296 |
| 130 | MP0000647_abnormal_sebaceous_gland | 0.89707591 |
| 131 | MP0008438_abnormal_cutaneous_collagen | 0.88375187 |
| 132 | MP0005058_abnormal_lysosome_morphology | 0.88367795 |
| 133 | MP0002006_tumorigenesis | 0.87858054 |
| 134 | MP0002067_abnormal_sensory_capabilities | 0.87513387 |
| 135 | MP0008569_lethality_at_weaning | 0.87359429 |
| 136 | MP0006036_abnormal_mitochondrial_physio | 0.86072647 |
| 137 | MP0009765_abnormal_xenobiotic_induced | 0.85577310 |
| 138 | MP0000026_abnormal_inner_ear | 0.85476607 |
| 139 | MP0004808_abnormal_hematopoietic_stem | 0.81445017 |
| 140 | MP0002938_white_spotting | 0.81002796 |
| 141 | MP0005075_abnormal_melanosome_morpholog | 0.80474498 |
| 142 | MP0003633_abnormal_nervous_system | 0.79271385 |
| 143 | MP0004036_abnormal_muscle_relaxation | 0.78756184 |
| 144 | MP0000490_abnormal_crypts_of | 0.77489706 |
| 145 | MP0000249_abnormal_blood_vessel | 0.76544676 |
| 146 | MP0002063_abnormal_learning/memory/cond | 0.76269010 |
| 147 | MP0002138_abnormal_hepatobiliary_system | 0.75820241 |
| 148 | MP0001727_abnormal_embryo_implantation | 0.75692032 |
| 149 | MP0000467_abnormal_esophagus_morphology | 0.75366725 |
| 150 | MP0001663_abnormal_digestive_system | 0.75285217 |
| 151 | MP0005083_abnormal_biliary_tract | 0.74885317 |
| 152 | MP0001340_abnormal_eyelid_morphology | 0.74830740 |
| 153 | MP0005164_abnormal_response_to | 0.74517696 |
| 154 | MP0006072_abnormal_retinal_apoptosis | 0.73963946 |
| 155 | MP0002152_abnormal_brain_morphology | 0.72713698 |
| 156 | MP0003195_calcinosis | 0.71190163 |
| 157 | MP0009250_abnormal_appendicular_skeleto | 0.70326187 |
| 158 | MP0009840_abnormal_foam_cell | 0.70017246 |
| 159 | MP0004883_abnormal_blood_vessel | 0.69939257 |
| 160 | MP0005623_abnormal_meninges_morphology | 0.69840241 |
| 161 | MP0008877_abnormal_DNA_methylation | 0.69550358 |
| 162 | MP0003045_fibrosis | 0.69008890 |
| 163 | MP0005390_skeleton_phenotype | 0.68281254 |
| 164 | MP0008874_decreased_physiological_sensi | 0.67827815 |
| 165 | MP0005165_increased_susceptibility_to | 0.67739766 |
| 166 | MP0005319_abnormal_enzyme/_coenzyme | 0.67304965 |
| 167 | MP0002733_abnormal_thermal_nociception | 0.66774623 |
| 168 | MP0000639_abnormal_adrenal_gland | 0.65289302 |
| 169 | MP0002933_joint_inflammation | 0.64833133 |
| 170 | MP0000631_abnormal_neuroendocrine_gland | 0.64017604 |
| 171 | MP0006082_CNS_inflammation | 0.63762337 |
| 172 | MP0002019_abnormal_tumor_incidence | 0.63361832 |
| 173 | MP0004133_heterotaxia | 0.62802126 |
| 174 | MP0006054_spinal_hemorrhage | 0.60957728 |
| 175 | MP0003656_abnormal_erythrocyte_physiolo | 0.60149537 |
| 176 | MP0001177_atelectasis | 0.59134049 |
| 177 | MP0003795_abnormal_bone_structure | 0.59054467 |
| 178 | MP0003137_abnormal_impulse_conducting | 0.58398282 |
| 179 | MP0001986_abnormal_taste_sensitivity | 0.57535302 |
| 180 | MP0005253_abnormal_eye_physiology | 0.57417534 |
| 181 | MP0002332_abnormal_exercise_endurance | 0.56636149 |
| 182 | MP0008873_increased_physiological_sensi | 0.55206345 |
| 183 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54943988 |
| 184 | MP0005646_abnormal_pituitary_gland | 0.53937642 |
| 185 | MP0000015_abnormal_ear_pigmentation | 0.53672233 |
| 186 | MP0000609_abnormal_liver_physiology | 0.53103465 |
| 187 | MP0005167_abnormal_blood-brain_barrier | 0.52608205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 7.00386100 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 7.00386100 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.34083963 |
| 4 | Sensory axonal neuropathy (HP:0003390) | 6.08463338 |
| 5 | Parakeratosis (HP:0001036) | 5.22711683 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.22588970 |
| 7 | Abnormality of the corticospinal tract (HP:0002492) | 5.01769528 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.85021744 |
| 9 | Myositis (HP:0100614) | 4.84595927 |
| 10 | Stomatitis (HP:0010280) | 4.80447560 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.74583647 |
| 12 | Peripheral hypomyelination (HP:0007182) | 4.68111597 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.66044600 |
| 14 | Eczematoid dermatitis (HP:0000976) | 4.52642780 |
| 15 | Cerebral hypomyelination (HP:0006808) | 4.48164473 |
| 16 | Cerebral inclusion bodies (HP:0100314) | 4.40655681 |
| 17 | Orchitis (HP:0100796) | 4.15742410 |
| 18 | Obstructive lung disease (HP:0006536) | 4.12981744 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 4.12981744 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 4.03817041 |
| 21 | Optic neuritis (HP:0100653) | 4.03817041 |
| 22 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.96131886 |
| 23 | Spastic gait (HP:0002064) | 3.75361371 |
| 24 | Prolonged bleeding time (HP:0003010) | 3.72114768 |
| 25 | Meningitis (HP:0001287) | 3.71503861 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.70072108 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.67504838 |
| 28 | Abnormal auditory evoked potentials (HP:0006958) | 3.66775525 |
| 29 | Recurrent skin infections (HP:0001581) | 3.64497834 |
| 30 | Onion bulb formation (HP:0003383) | 3.60549471 |
| 31 | Petechiae (HP:0000967) | 3.59856138 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 3.54871310 |
| 33 | Supranuclear gaze palsy (HP:0000605) | 3.48192525 |
| 34 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.46695938 |
| 35 | Hypochromic microcytic anemia (HP:0004840) | 3.40444168 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.40403240 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 3.40403240 |
| 38 | T lymphocytopenia (HP:0005403) | 3.36751805 |
| 39 | Abnormality of T cell number (HP:0011839) | 3.34833667 |
| 40 | Encephalitis (HP:0002383) | 3.34267329 |
| 41 | Akinesia (HP:0002304) | 3.33889985 |
| 42 | Vasculitis (HP:0002633) | 3.32075218 |
| 43 | Purpura (HP:0000979) | 3.29619128 |
| 44 | Autoimmune hemolytic anemia (HP:0001890) | 3.27297515 |
| 45 | Spastic paraparesis (HP:0002313) | 3.26447380 |
| 46 | Epistaxis (HP:0000421) | 3.23252237 |
| 47 | Alacrima (HP:0000522) | 3.19932019 |
| 48 | Granulocytopenia (HP:0001913) | 3.16405623 |
| 49 | Thickened helices (HP:0000391) | 3.15042595 |
| 50 | Hypoplastic pelvis (HP:0008839) | 3.14017627 |
| 51 | Abnormality of T cells (HP:0002843) | 3.11353105 |
| 52 | Dysmetria (HP:0001310) | 3.09966686 |
| 53 | Pulmonary infiltrates (HP:0002113) | 3.08278916 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 3.07158375 |
| 55 | Chest pain (HP:0100749) | 3.06089470 |
| 56 | Increased IgM level (HP:0003496) | 3.03208683 |
| 57 | Intention tremor (HP:0002080) | 3.02109147 |
| 58 | Autoamputation (HP:0001218) | 2.99667245 |
| 59 | Increased IgE level (HP:0003212) | 2.95555122 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.95099713 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.95006507 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.91375668 |
| 63 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.86970657 |
| 64 | Urticaria (HP:0001025) | 2.86511321 |
| 65 | Hemoptysis (HP:0002105) | 2.86300816 |
| 66 | Hypochromic anemia (HP:0001931) | 2.85946899 |
| 67 | IgM deficiency (HP:0002850) | 2.85359140 |
| 68 | Leukocytosis (HP:0001974) | 2.85201600 |
| 69 | Insidious onset (HP:0003587) | 2.84189577 |
| 70 | Termporal pattern (HP:0011008) | 2.84189577 |
| 71 | Increased serum pyruvate (HP:0003542) | 2.84043923 |
| 72 | Abnormality of glycolysis (HP:0004366) | 2.84043923 |
| 73 | Recurrent viral infections (HP:0004429) | 2.83937053 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81910157 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81910157 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81910157 |
| 77 | Abnormality of T cell physiology (HP:0011840) | 2.81190994 |
| 78 | Eosinophilia (HP:0001880) | 2.80957274 |
| 79 | Leukodystrophy (HP:0002415) | 2.80631387 |
| 80 | Myokymia (HP:0002411) | 2.80523243 |
| 81 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.79552261 |
| 82 | CNS hypomyelination (HP:0003429) | 2.79328094 |
| 83 | Pulmonary embolism (HP:0002204) | 2.77358430 |
| 84 | Keratoconjunctivitis (HP:0001096) | 2.76430981 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 2.73431662 |
| 86 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.71593936 |
| 87 | Spontaneous hematomas (HP:0007420) | 2.70958531 |
| 88 | Gingival bleeding (HP:0000225) | 2.67987320 |
| 89 | Abnormality of the prostate (HP:0008775) | 2.64641173 |
| 90 | Muscle fiber splitting (HP:0003555) | 2.64243157 |
| 91 | Stridor (HP:0010307) | 2.62192990 |
| 92 | Anteriorly placed anus (HP:0001545) | 2.62111640 |
| 93 | Absent septum pellucidum (HP:0001331) | 2.61852755 |
| 94 | Cerebral hemorrhage (HP:0001342) | 2.60794616 |
| 95 | Arterial thrombosis (HP:0004420) | 2.59477674 |
| 96 | Gangrene (HP:0100758) | 2.57209339 |
| 97 | Agammaglobulinemia (HP:0004432) | 2.54218239 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.51290997 |
| 99 | Gingivitis (HP:0000230) | 2.49059914 |
| 100 | Hypergammaglobulinemia (HP:0010702) | 2.48656507 |
| 101 | Pustule (HP:0200039) | 2.48643555 |
| 102 | Decreased lacrimation (HP:0000633) | 2.48540439 |
| 103 | Inflammation of the large intestine (HP:0002037) | 2.47681397 |
| 104 | Cellulitis (HP:0100658) | 2.46970740 |
| 105 | IgG deficiency (HP:0004315) | 2.43984081 |
| 106 | Renal Fanconi syndrome (HP:0001994) | 2.40319113 |
| 107 | Episodic fever (HP:0001954) | 2.39655547 |
| 108 | Abnormality of eosinophils (HP:0001879) | 2.37304299 |
| 109 | Morphological abnormality of the inner ear (HP:0011390) | 2.37025901 |
| 110 | Premature skin wrinkling (HP:0100678) | 2.36751910 |
| 111 | Microcytic anemia (HP:0001935) | 2.36500801 |
| 112 | Joint swelling (HP:0001386) | 2.35264267 |
| 113 | Gastrointestinal inflammation (HP:0004386) | 2.34808338 |
| 114 | Retinal dysplasia (HP:0007973) | 2.33207099 |
| 115 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.32765060 |
| 116 | Anorexia (HP:0002039) | 2.31832063 |
| 117 | Severe combined immunodeficiency (HP:0004430) | 2.30039329 |
| 118 | Abnormality of B cell number (HP:0010975) | 2.29619010 |
| 119 | Abnormality of the pleura (HP:0002103) | 2.29487327 |
| 120 | Increased cerebral lipofuscin (HP:0011813) | 2.25783184 |
| 121 | Ankle clonus (HP:0011448) | 2.25111075 |
| 122 | Scanning speech (HP:0002168) | 2.23739528 |
| 123 | Glomerulopathy (HP:0100820) | 2.22190182 |
| 124 | Abnormality of the septum pellucidum (HP:0007375) | 2.20561928 |
| 125 | Hepatosplenomegaly (HP:0001433) | 2.20296187 |
| 126 | Skin rash (HP:0000988) | 2.19680370 |
| 127 | Systemic lupus erythematosus (HP:0002725) | 2.19612273 |
| 128 | Lymphopenia (HP:0001888) | 2.19553832 |
| 129 | Amyloidosis (HP:0011034) | 2.17984079 |
| 130 | Split foot (HP:0001839) | 2.17925623 |
| 131 | Recurrent bronchitis (HP:0002837) | 2.17785346 |
| 132 | Coronal craniosynostosis (HP:0004440) | 2.17645649 |
| 133 | Loss of speech (HP:0002371) | 2.17535077 |
| 134 | B lymphocytopenia (HP:0010976) | 2.15219432 |
| 135 | Foot dorsiflexor weakness (HP:0009027) | 2.13323561 |
| 136 | Polyneuropathy (HP:0001271) | 2.12970087 |
| 137 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11190565 |
| 138 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.10092550 |
| 139 | Abnormality of iron homeostasis (HP:0011031) | 2.09778389 |
| 140 | Increased serum ferritin (HP:0003281) | 2.09510471 |
| 141 | Decreased motor nerve conduction velocity (HP:0003431) | 2.08673724 |
| 142 | White forelock (HP:0002211) | 2.08539840 |
| 143 | Dysostosis multiplex (HP:0000943) | 2.08174474 |
| 144 | Aplastic anemia (HP:0001915) | 2.06135765 |
| 145 | Adrenal hypoplasia (HP:0000835) | 2.06021465 |
| 146 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04792990 |
| 147 | Barrel-shaped chest (HP:0001552) | 2.04587973 |
| 148 | Abnormality of the pericardium (HP:0001697) | 2.03341587 |
| 149 | Aplasia involving bones of the extremities (HP:0009825) | 2.01683137 |
| 150 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.01683137 |
| 151 | Aplasia of the phalanges of the hand (HP:0009802) | 2.01683137 |
| 152 | Clumsiness (HP:0002312) | 2.01636483 |
| 153 | Patchy hypopigmentation of hair (HP:0011365) | 2.01450592 |
| 154 | Poor speech (HP:0002465) | 2.01319679 |
| 155 | Colitis (HP:0002583) | 1.99495224 |
| 156 | Partial agenesis of the corpus callosum (HP:0001338) | 1.97956180 |
| 157 | Osteomyelitis (HP:0002754) | 1.96640420 |
| 158 | Premature loss of primary teeth (HP:0006323) | 1.95812190 |
| 159 | Vacuolated lymphocytes (HP:0001922) | 1.94372757 |
| 160 | Paraparesis (HP:0002385) | 1.94291717 |
| 161 | Infantile muscular hypotonia (HP:0008947) | 1.93863364 |
| 162 | Gowers sign (HP:0003391) | 1.93535316 |
| 163 | Spastic tetraparesis (HP:0001285) | 1.93028316 |
| 164 | Combined immunodeficiency (HP:0005387) | 1.92715326 |
| 165 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.91535316 |
| 166 | Humeroradial synostosis (HP:0003041) | 1.91233744 |
| 167 | Synostosis involving the elbow (HP:0003938) | 1.91233744 |
| 168 | Partial duplication of thumb phalanx (HP:0009944) | 1.89979559 |
| 169 | Abnormality of the foot musculature (HP:0001436) | 1.89975332 |
| 170 | Stenosis of the external auditory canal (HP:0000402) | 1.89887148 |
| 171 | Pheochromocytoma (HP:0002666) | 1.88773325 |
| 172 | Erythroderma (HP:0001019) | 1.88276385 |
| 173 | Cupped ear (HP:0000378) | 1.87830130 |
| 174 | Abnormal gallbladder physiology (HP:0012438) | 1.87291888 |
| 175 | Cholecystitis (HP:0001082) | 1.87291888 |
| 176 | Metabolic alkalosis (HP:0200114) | 1.86980834 |
| 177 | Diminished movement (HP:0002374) | 1.86183370 |
| 178 | Lower limb muscle weakness (HP:0007340) | 1.85552666 |
| 179 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.83373772 |
| 180 | Hypoplasia of the iris (HP:0007676) | 1.83112157 |
| 181 | Hyporeflexia of lower limbs (HP:0002600) | 1.79962433 |
| 182 | Generalized myoclonic seizures (HP:0002123) | 1.78966160 |
| 183 | Increased circulating renin level (HP:0000848) | 1.77484388 |
| 184 | Chin dimple (HP:0010751) | 1.76022952 |
| 185 | Prolonged neonatal jaundice (HP:0006579) | 1.74808915 |
| 186 | Methylmalonic acidemia (HP:0002912) | 1.74734368 |
| 187 | Megalencephaly (HP:0001355) | 1.72551023 |
| 188 | Hypokalemic alkalosis (HP:0001949) | 1.71666606 |
| 189 | Urinary incontinence (HP:0000020) | 1.71369672 |
| 190 | Esophageal atresia (HP:0002032) | 1.70921899 |
| 191 | Irregular epiphyses (HP:0010582) | 1.70573595 |
| 192 | Hypophosphatemic rickets (HP:0004912) | 1.68079903 |
| 193 | Hypomagnesemia (HP:0002917) | 1.67635345 |
| 194 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.67312818 |
| 195 | Absent epiphyses (HP:0010577) | 1.67312818 |
| 196 | Anomalous pulmonary venous return (HP:0010772) | 1.66797220 |
| 197 | Progressive inability to walk (HP:0002505) | 1.64450886 |
| 198 | Progressive neurologic deterioration (HP:0002344) | 1.64225941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.33000985 |
| 2 | RIPK4 | 4.65585147 |
| 3 | OXSR1 | 4.58963485 |
| 4 | TXK | 4.20347460 |
| 5 | MAP4K1 | 3.74484445 |
| 6 | FES | 3.06621835 |
| 7 | BCR | 3.05978972 |
| 8 | EPHB1 | 2.94844792 |
| 9 | CDK19 | 2.65976236 |
| 10 | PBK | 2.60325179 |
| 11 | MAP2K3 | 2.59781682 |
| 12 | CSK | 2.57143029 |
| 13 | BLK | 2.56661582 |
| 14 | PKN1 | 2.53042257 |
| 15 | MET | 2.48112726 |
| 16 | WNK4 | 2.46654807 |
| 17 | LIMK1 | 2.31353643 |
| 18 | IRAK4 | 2.26656394 |
| 19 | SYK | 2.21540887 |
| 20 | BTK | 2.19849702 |
| 21 | TNK2 | 2.15189536 |
| 22 | CSNK1G3 | 2.14330252 |
| 23 | MAPKAPK5 | 2.11157971 |
| 24 | ERN1 | 2.08296086 |
| 25 | TBK1 | 2.07620077 |
| 26 | ZAP70 | 2.07097454 |
| 27 | TYK2 | 2.05728114 |
| 28 | FGFR2 | 2.01649063 |
| 29 | CSNK1A1L | 2.01640413 |
| 30 | GRK6 | 1.98566713 |
| 31 | NEK6 | 1.98389992 |
| 32 | WNK1 | 1.94251969 |
| 33 | PRPF4B | 1.84280405 |
| 34 | CSNK1G1 | 1.83700447 |
| 35 | IKBKE | 1.69308779 |
| 36 | CSF1R | 1.69014282 |
| 37 | JAK3 | 1.67357910 |
| 38 | TEC | 1.66090738 |
| 39 | MST4 | 1.60479216 |
| 40 | MAP3K11 | 1.59245842 |
| 41 | HCK | 1.58064291 |
| 42 | LYN | 1.54789757 |
| 43 | ARAF | 1.53689399 |
| 44 | CSNK1G2 | 1.53396879 |
| 45 | ROCK2 | 1.50508800 |
| 46 | TAOK2 | 1.50263301 |
| 47 | MAP3K13 | 1.49272122 |
| 48 | ERBB4 | 1.46276834 |
| 49 | CAMK2B | 1.46252647 |
| 50 | LCK | 1.44572332 |
| 51 | TNIK | 1.44075751 |
| 52 | MAP3K3 | 1.43861242 |
| 53 | KDR | 1.42591123 |
| 54 | UHMK1 | 1.39585939 |
| 55 | TESK2 | 1.38550399 |
| 56 | MARK3 | 1.38143280 |
| 57 | ICK | 1.37521173 |
| 58 | PNCK | 1.36139506 |
| 59 | TAOK1 | 1.35034184 |
| 60 | PAK6 | 1.34061492 |
| 61 | CLK1 | 1.33880236 |
| 62 | MAP3K14 | 1.33840881 |
| 63 | NTRK1 | 1.31829933 |
| 64 | JAK2 | 1.29335365 |
| 65 | FGR | 1.26582817 |
| 66 | IKBKB | 1.24207235 |
| 67 | KSR2 | 1.22561610 |
| 68 | KIT | 1.20058204 |
| 69 | TRPM7 | 1.19892608 |
| 70 | CAMK2D | 1.17062526 |
| 71 | MAP3K1 | 1.15877506 |
| 72 | MUSK | 1.12727698 |
| 73 | DYRK2 | 1.11211273 |
| 74 | EPHA4 | 1.09685350 |
| 75 | JAK1 | 1.07856290 |
| 76 | PIK3CG | 1.07780268 |
| 77 | PINK1 | 1.00190099 |
| 78 | MOS | 0.95238036 |
| 79 | MAP3K9 | 0.95068013 |
| 80 | SGK494 | 0.93363927 |
| 81 | SGK223 | 0.93363927 |
| 82 | PAK3 | 0.93343846 |
| 83 | CAMK2G | 0.92867874 |
| 84 | CDK14 | 0.91075418 |
| 85 | BCKDK | 0.89533854 |
| 86 | PRKCQ | 0.88395749 |
| 87 | MAP2K6 | 0.87107585 |
| 88 | BMPR1B | 0.86936417 |
| 89 | MAPK12 | 0.85155389 |
| 90 | MAPK15 | 0.84823119 |
| 91 | SIK3 | 0.84043641 |
| 92 | TYRO3 | 0.82309538 |
| 93 | MARK1 | 0.82261124 |
| 94 | CDK15 | 0.80281375 |
| 95 | MATK | 0.77436709 |
| 96 | CASK | 0.75870111 |
| 97 | EIF2AK1 | 0.75756239 |
| 98 | CAMK2A | 0.74559875 |
| 99 | CDK18 | 0.74336171 |
| 100 | MAP3K5 | 0.73110991 |
| 101 | CDK11A | 0.71121442 |
| 102 | SCYL2 | 0.69438371 |
| 103 | NME2 | 0.67854587 |
| 104 | MAPKAPK3 | 0.66470285 |
| 105 | HIPK2 | 0.65798218 |
| 106 | BRAF | 0.65600777 |
| 107 | CDK5 | 0.65302708 |
| 108 | GRK7 | 0.65238507 |
| 109 | IRAK3 | 0.63202676 |
| 110 | BMX | 0.62111821 |
| 111 | CSNK1D | 0.62043524 |
| 112 | RAF1 | 0.59384190 |
| 113 | PIM1 | 0.58282675 |
| 114 | MARK2 | 0.57467010 |
| 115 | RPS6KA5 | 0.56625390 |
| 116 | PDPK1 | 0.55478428 |
| 117 | PRKD1 | 0.55401100 |
| 118 | MAPKAPK2 | 0.54221740 |
| 119 | MAP3K12 | 0.53048220 |
| 120 | MAPK11 | 0.51859586 |
| 121 | PHKG2 | 0.51456566 |
| 122 | PHKG1 | 0.51456566 |
| 123 | BMPR2 | 0.51100674 |
| 124 | TESK1 | 0.50507848 |
| 125 | ITK | 0.49106684 |
| 126 | PTK2B | 0.48161005 |
| 127 | MELK | 0.47016525 |
| 128 | PRKCH | 0.47006133 |
| 129 | DAPK1 | 0.46739559 |
| 130 | FYN | 0.45595911 |
| 131 | PRKCE | 0.44678919 |
| 132 | PRKG1 | 0.43624967 |
| 133 | PAK1 | 0.42540009 |
| 134 | CSNK1A1 | 0.42490528 |
| 135 | LRRK2 | 0.42247358 |
| 136 | CAMKK2 | 0.42021620 |
| 137 | TGFBR2 | 0.41974337 |
| 138 | STK10 | 0.41791672 |
| 139 | DDR2 | 0.41614614 |
| 140 | VRK2 | 0.41071030 |
| 141 | MAP3K6 | 0.40346703 |
| 142 | GRK5 | 0.40178123 |
| 143 | PIK3CA | 0.39700227 |
| 144 | PRKCD | 0.37769656 |
| 145 | PRKACB | 0.36756634 |
| 146 | IRAK1 | 0.36311773 |
| 147 | BUB1 | 0.35599318 |
| 148 | STK11 | 0.34900264 |
| 149 | ILK | 0.34808535 |
| 150 | EIF2AK3 | 0.32646612 |
| 151 | MAP2K2 | 0.32146467 |
| 152 | SMG1 | 0.31384567 |
| 153 | MAPK7 | 0.31359876 |
| 154 | MYLK | 0.31202787 |
| 155 | CAMKK1 | 0.30769989 |
| 156 | NUAK1 | 0.28975246 |
| 157 | DAPK3 | 0.28783176 |
| 158 | IRAK2 | 0.28529772 |
| 159 | GSK3A | 0.25998089 |
| 160 | CSNK1E | 0.25976770 |
| 161 | MAPK4 | 0.25152923 |
| 162 | DAPK2 | 0.25051639 |
| 163 | NTRK2 | 0.24776705 |
| 164 | TAOK3 | 0.24172320 |
| 165 | PRKD2 | 0.24019987 |
| 166 | OBSCN | 0.23171902 |
| 167 | MAPK13 | 0.23110572 |
| 168 | KSR1 | 0.22862538 |
| 169 | ABL1 | 0.22585686 |
| 170 | PDK1 | 0.22182584 |
| 171 | ABL2 | 0.21223176 |
| 172 | YES1 | 0.21037816 |
| 173 | PRKACA | 0.20831611 |
| 174 | NME1 | 0.20055914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.04085800 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 5.00745998 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.40786005 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.54872449 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.43276537 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.39918384 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 3.38150337 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.30865623 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.26063479 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.84028427 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.74629464 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.57631629 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53743936 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49275511 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.48522262 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.44628651 |
| 17 | Protein export_Homo sapiens_hsa03060 | 2.43097476 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.37597863 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.34409353 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.31172569 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.28480381 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.26369576 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16403816 |
| 24 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.09255451 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08296890 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.98622118 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96000796 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.94023588 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.93818891 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.90919790 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.87290735 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86878167 |
| 33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.86526439 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79805922 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.77408598 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.76830497 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.73618082 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.73355443 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63508709 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.57642686 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.50620991 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.41787694 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.40147300 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.39823071 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.39482117 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39051879 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.38426102 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37832638 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37301091 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35648888 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.34809613 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 1.34362467 |
| 53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.32364437 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31348443 |
| 55 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.28963744 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.28524424 |
| 57 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25226893 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.22616906 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 1.21334299 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20341778 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18647545 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13230178 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 1.11495639 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10363788 |
| 65 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.05618149 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05143810 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 1.04231175 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04035780 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03073955 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 1.00405707 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.00183691 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98215567 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.97761835 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95921723 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88846816 |
| 76 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.87991623 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86779906 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86576682 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85909246 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82763173 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81109028 |
| 82 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81044058 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80989601 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80603063 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80398834 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80200886 |
| 87 | Proteasome_Homo sapiens_hsa03050 | 0.79880051 |
| 88 | Huntingtons disease_Homo sapiens_hsa05016 | 0.78612444 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78163512 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77728202 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77389532 |
| 92 | GABAergic synapse_Homo sapiens_hsa04727 | 0.73583834 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.73024143 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72428578 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69623320 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69502851 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69415433 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69086879 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68997610 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68210493 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.67807332 |
| 102 | Malaria_Homo sapiens_hsa05144 | 0.66775601 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65469773 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.65439656 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65435964 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.65084196 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64851078 |
| 108 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63196189 |
| 109 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62858345 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62360758 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61717783 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59992194 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59452838 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.58309104 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55056865 |
| 116 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54694814 |
| 117 | Morphine addiction_Homo sapiens_hsa05032 | 0.53723457 |
| 118 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53697318 |
| 119 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53283306 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.51284238 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50693195 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49993631 |
| 123 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49649079 |
| 124 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49550642 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48769054 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48122779 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47828858 |
| 128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45476313 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44168746 |
| 130 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44042934 |
| 131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43728543 |
| 132 | Phototransduction_Homo sapiens_hsa04744 | 0.42919810 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.42904377 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42702538 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42196288 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42131522 |
| 137 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40705793 |
| 138 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.40447679 |
| 139 | Phagosome_Homo sapiens_hsa04145 | 0.39561195 |
| 140 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37457401 |
| 141 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37168636 |
| 142 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35994521 |
| 143 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35473666 |
| 144 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34567573 |
| 145 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32065635 |
| 146 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31999967 |
| 147 | RNA polymerase_Homo sapiens_hsa03020 | 0.28565653 |
| 148 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27562671 |
| 149 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26232523 |
| 150 | Salivary secretion_Homo sapiens_hsa04970 | 0.26205613 |
| 151 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.25896441 |
| 152 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25253129 |
| 153 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25036526 |
| 154 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.23904635 |
| 155 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.23850542 |
| 156 | Amoebiasis_Homo sapiens_hsa05146 | 0.23009578 |
| 157 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.22905342 |
| 158 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.22528776 |
| 159 | Gap junction_Homo sapiens_hsa04540 | 0.21744157 |
| 160 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21314801 |
| 161 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.20620975 |
| 162 | Circadian entrainment_Homo sapiens_hsa04713 | 0.20325070 |
| 163 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20237411 |
| 164 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.19799582 |
| 165 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19225731 |
| 166 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.18993606 |
| 167 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18034093 |
| 168 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17059033 |
| 169 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.14436859 |
| 170 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.13895498 |
| 171 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13634353 |
| 172 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.13559262 |
| 173 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11932930 |
| 174 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10690365 |
| 175 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09639246 |
| 176 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.09176236 |

